BIT

0.00%

1.9¢ biotron limited

Sounds great but you missed the part about BIT225 having zero...

First 45 Last

Share
Profile

Follow
Warnie

17,233 Posts.

954

06/02/20

17:25

Post #: 42786667
Share

Originally posted by elephantsong: ↑

I think a few people noticed the purchase by SL and RT.

I mean SL is an expert in Hepatits B.
A deal here would be in the vicintity of US 200-300+ alone.

RT....well he has deep pockets. He actually bought some more on market!

BIT is way undervalued....before the new coronavirus came along.

What people fail to realize is BIt is different mode of action from a lot of the new stuff.
It can be rapidly deployed.
They have a platform and a big library of compounds ... which have broad antiviral capabilities.Drugs capable of targeting viruses
in reservoir cells.

100 billion is higher end of the scale and probably too early ....but possible.
10 billion is very conservative.

If they can develop a new compound for the New CoronaVirus, within 1 month, it shows the true value of their platform.
Such Rapid development of compounds to target such pandemics is highly attractive.

National Security against Biothreats is becoming a priority for governments and others.

China could easily do a deal within a month with Biotron for US$500 million.
They could easily fastrack approval for New CoronaVirus.

A city of 10 million people in lockdown.

Biotron already have CoronaVirus expertise.

So what is the value of BIT225 and other compounds?
Hep C, Hep B, EBV, Zika, SARS, Flu, Dengue compounds?
They have over 400!

Whilst $100 billions seems high at this stage....$10 Billion is still looking conservative IMHO.

Note. BIT225 has undergone 12 years of testing. Extremely high safety profile.
And it restores immune response.

There will be a revaluation of BIT if the anti NewCoronaVirus compounds works.
Remember they have the virus isolated and in labs already. This is unprecedented.

Expand

Sounds great but you missed the part about BIT225 having zero FDA approval and no proof of eradicating coronavirus for that matter

Enjoy

BIT Price at posting: 10.0¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 79 more messages in this thread...

First 45 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$7.664K	403.3K

Buyers (Bids)

No.	Vol.	Price($)
1	100000	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	1202498	5

View Market Depth

No.	Vol.	Price($)
1	100000	0.019
10	1774771	0.018
10	1139476	0.017
12	3734154	0.016
10	1205000	0.015

Price($)	Vol.	No.
0.020	1052498	3
0.021	500000	1
0.022	1431102	4
0.023	1100772	2
0.024	153949	2

Last trade - 13.42pm 27/09/2024 (20 minute delay)

BIT (ASX) Chart

Sounds great but you missed the part about BIT225 having zero...

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sounds great but you missed the part about BIT225 having zero...

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News